Polyclonal Antibody to Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 3 (SPLUNC3)

BPIFA3; C20orf71; BPI fold-containing family A member 3

  • Polyclonal Antibody to Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 3 (SPLUNC3) Packages (Simulation)
  • Polyclonal Antibody to Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 3 (SPLUNC3) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SPECIFITY of the Polyclonal Antibody to Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 3 (SPLUNC3)

The antibody is a rabbit polyclonal antibody raised against SPLUNC3. It has been selected for its ability to recognize SPLUNC3 in immunohistochemical staining and western blotting.

USAGE of the Polyclonal Antibody to Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 3 (SPLUNC3)

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

STORAGE of the of the Polyclonal Antibody to Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 3 (SPLUNC3)

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY of the Polyclonal Antibody to Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 3 (SPLUNC3)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

GUESTBOOK